SAHPRA did not provide the names of the applicants or the timelines for potential approval
Rybelsus Weight Loss Side Effects The side effect profile is dominated by gastrointestinal issues
Separately: per prior industry coverage of the 2026 oral GLP-1 launch, the Wegovy pill (oral semaglutide 25mg) received FDA approval on December 22, 2025 and launched across more than 70,000 US pharmacies in January 2026, with cash-pay pricing starting around $149 per month for the lowest dose
Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al
GLP-1 gummies and capsules from other brands The supplement market is flooded with products labeled "GLP-1 support" that contain berberine, cinnamon extract, green tea extract, and other ingredients with loose connections to glucose metabolism or GLP-1 signaling
This isnt rocket science, but there are specific steps you need to follow